Nex Ha Hyaluronate Sodium

Sodium hyaluronate injectable for intra-articular treatment of equine joint disease. Sodium hyaluronate injectable (high-molecular-weight HA for equine joints). Mechanism: viscosupplementation — restores synovial fluid viscoelastic properties; stimulates endogenous HA synthesis by synoviocytes; anti-inflammatory via CD44 receptor-mediated signaling; scavenges reactive oxygen species. Intra-articular injection. Key information Sodium hyaluronate IA injection. Refrigerate. Aseptic technique. Single-use. Equine joint injection.

Oral chewable tablet: Administer orally. May be given with food to improve compliance and reduce GI upset. Administer with food to reduce GI adverse effects. or treat. Administer monthly. Use correct weight-band product. Store at room temperature; protect from light. If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

GI: vomiting, diarrhea, decreased appetite, hypersalivation, lethargy (most common). CNS: tremors, ataxia, seizures (rare — post-marketing; use caution in dogs with seizure history). Isoxazoline class adverse effects.

For animals Use with caution in dogs with known seizure history (isoxazoline class). Not for puppies <8 weeks or <4 lbs. Not approved for use in food-producing animals. For people handling this medication Wash hands thoroughly with soap and water after handling. Avoid contact with eyes; if contact occurs, flush with water for 15 minutes and seek medical attention. Keep out of reach of children. If accidental ingestion occurs, contact Poison Control (1-800-222-1222). Isoxazoline chewable — Wash hands thoroughly with soap and water after handling. after handling. Keep out of reach of children.

Contact your veterinarian. HA joint product — overdose managed by veterinary staff.